Indications for the intravenous use of immunoglobulins

Revista Clinica Espanola

Volumn 202, Issue 3, 2002, Pages 157-160

  Garcia Suarez J ^a   de Miguel Llorente, D ^a   Burgaleta Alonso de Ozalla, C ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ANAPHYLAXIS; ARTICLE; ASEPTIC MENINGITIS; CHRONIC LYMPHATIC LEUKEMIA; COMORBIDITY; DRUG INDICATION; DRUG USE; DYSPNEA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGAMMAGLOBULINEMIA; HYPOTENSION; IMMUNE DEFICIENCY; KIDNEY FAILURE; MULTIPLE MYELOMA; RISK BENEFIT ANALYSIS; THROMBOSIS; VOMITING;

EID: 0036316266     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(02)71013-8     Document Type: Article

References (11)

1. Estado actual del tratamiento con inmunoglobulinas por vía intravenosa
2. Inmunoglobulinas de administración intravenosa. Actualización de sus indicaciones
3. The use of intravenous immune globulin in immunodeficiency diseases
4. Current perspectives on the use of immunoglobulin
5. Intravenous immunoglobulin treatment in hematological diseases
6. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
7. Intravenous immunoglobulin treatment of neurological autoimmune diseases
8. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders
9. Sepsis and polyspecific intravenous immunoglobulins
10. Dermatological uses of high doses intravenous immunoglobulin
11. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis